Chronoscale Holdings (CHRN)CFO sold ~$54K
Jerome Wong, CFO at Chronoscale Holdings, sold ~$54K of Chronoscale Holdings shares.
- ~$54K
- Approx. value · 11K sh @ $4.80
- 26K
- Holds after · shares reported
- Traded
- Nov 10, 2025
- Filed
- Nov 13, 2025
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Sep 12, 2025Company filing · Form 8-K · Material agreement, Agreement endedSigned an important agreement, and ended an important agreement (and 1 more item)
- Oct 28, 2025Company filing · Form 8-K · ResultsReported its results
- Oct 28, 2025Company filing · Form 8-K · Unregistered shares, Other newsSold new shares without registering them, and reported other company news
- Nov 5, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On November 5, 2025, in order to assist in retention and to help motivate each of Scott Davis, Jerome Wong and Jason Jones (each, an “Executive”) to drive stockholder growth and achieve the Company’s strategic goals, the board of directors of Ekso Bionics Holdings, Inc. (the “Company”) approved the following equity awards grants: (A) an award of restricted stock units (“RSUs”) to each of Messrs. Davis, Wong and…”
- Nov 10, 2025 · this disclosureInsiderCFO sold ~$54K of CHRN shares in the open market
What came next
- Nov 10, 2025Insider · 2 peopleInsiders: 2 sales (~$159K)
- Dec 9, 2025Insider · 2 peopleInsiders: 2 sales (~$7K)
- Jan 6, 2026InsiderOfficer sold ~$12K of CHRN shares in the open market
- Jan 20, 2026Company filing · Form 8-K · Material agreement, Unregistered sharesSigned an important agreement, and sold new shares without registering them (and 1 more item)
- Feb 6, 2026Insider · 8 days before results10% owner purchased ~$1.9K of CHRN shares in the open market
- Feb 9, 2026Insider · 5 days before results10% owner purchased ~$48K of CHRN shares in the open market
- Feb 10, 2026Insider · 4 days before results10% owner purchased ~$101K of CHRN shares in the open market
- Feb 11, 2026Insider · Largest insider buy since 201610% owner purchased ~$200K of CHRN shares in the open market
- Feb 12, 2026Insider · 1 personInsiders: 2 purchases (~$374K)
- Feb 13, 2026Insider · 1 personInsiders: 2 purchases (~$246K)
- Feb 14, 2026Company filing · Form 8-K · Material agreement, ResultsControl of the company changed hands, and changed a top executive or board member (and 5 more items)“On February 14, 2026, the Board approved the 2026 Omnibus Equity Incentive Plan (the “2026 Plan”), which will be adopted in connection with the Business Combination, will only become effective immediately upon Closing and is subject to stockholder approval.”
- Feb 19, 2026Insider · 1 personInsiders: 2 purchases (~$203K)
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Chronoscale Holdings
OQRO holds no insider, Congress, fund or contract record for Chronoscale Holdings dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CHRN page.
Other recent filings by Jerome Wong, Chief Financial Officer
- SEC Form 4 at Chronoscale Holdings (CHRN)Mar 21, 2026
- SEC Form 4 at Chronoscale Holdings (CHRN)Dec 11, 2025
The full history of Jerome Wong, Chief Financial Officer is on the profile page.
How this filing works
Other disclosures at Chronoscale Holdings
- SEC Form 4Mar 21, 2026
- SEC Form 4Mar 21, 2026
- SEC Form 4Feb 21, 2026
- SEC Form 4Feb 20, 2026
- SEC Form 4Feb 18, 2026
- SEC Form 4Feb 18, 2026
Everything OQRO holds on this company is on its CHRN page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
